Quest (DGX) (POM) (PSTI) (QCOR) (DMAN) (CYBX) Ratings, Price Targets

Quest Diagnostics Inc (DGX), Potomac Electric Pow (POM), Pluristem Therapeutics (PSTI), DemandTec, Inc. (DMAN), Questcor Pharmaceuticals, Inc. (QCOR) and Cyberonics (CYBX) ratings and price targets.

Bank of America (NYSE:BAC) reiterated its “Buy” rating on Quest Diagnostics Inc (DGX). They have a price target of $60.00 on the company.

Credit Suisse (NYSE:CS) upgraded Potomac Electric Pow (POM) from a “Neutral” rating to an “Outperform” rating. They have a price target of $23.00 on the company.

Global Hunter Securities initiated coverage on Pluristem Therapeutics (PSTI). They placed a “Buy” rating and a price target of $5.00 on the company.

Leerink Swann initiated coverage on Questcor Pharmaceuticals, Inc. (QCOR). They placed an “Outperform” rating on the company.

Piper Jaffray (NYSE:PJC) raised its price target on Cyberonics (CYBX) to $36.00. They have an “Overweight” rating on the company.

Pacific Crest downgraded DemandTec, Inc. (DMAN) from an “Outperform” rating to a “Sector Perform” rating.